ArticleFrontiers in oncology2025
Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This work investigates the use of a spherical projection-based U-Net (SPU-Net) segmentation model to improve meningioma segmentation performance and allow for uncertainty quantification. Methods: A total of 76 supratentorial meningioma patients treated with radiotherapy were studied. Gross tumor volumes (GTVs) were contoured by a single experienced radiation oncologist on high-resolution contrast-enhanced T1 MRI scans (T1ce), and both T1 and T1ce images were utilized for segmentation. SPU-Net, an adaptation of U-Net incorporating spherical image projection to map 2D images onto a spherical surface, was proposed. As an equivalence of a nonlinear image transform, projections enhance locoregional details while maintaining the global field of view. By employing multiple projection centers, SPU-Net generates various GTV segmentation predictions, the variance indicating the model's uncertainty. This uncertainty is quantified on a pixel-wise basis using entropy calculations and aggregated through Otsu's method for a final segmentation. Results/conclusion: The SPU-Net model poses an advantage over traditional U-Net models by providing a quantitative method of displaying segmentation uncertainty. Regarding segmentation performance, SPU-Net demonstrated comparable results to a traditional U-Net in sensitivity (0.758 vs. 0.746), Dice similarity coefficient (0.760 vs. 0.742), reduced mean Hausdorff distance (mHD) (0.612 cm vs 0.744 cm), and reduced 95% Hausdorff distance (HD95) (2.682 cm vs 2.912 cm). SPU-Net not only is comparable to U-Net in segmentation performance but also offers a significant advantage by providing uncertainty quantification. The added SPU-Net uncertainty mapping revealed low uncertainty in accurate segments (e.g., within GTV or healthy tissue) and higher uncertainty in problematic areas (e.g., GTV boundaries, dural tail), providing valuable insights for potential manual corrections. This advancement is particularly valuable given the complex extra-axial nature of meningiomas and involvement with dural tissue. The capability to quantify uncertainty makes SPU-Net a more advanced and informative tool for segmentation, without sacrificing performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.